BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Labrie M, Brugge JS, Mills GB, Zervantonakis IK. Therapy resistance: opportunities created by adaptive responses to targeted therapies in cancer. Nat Rev Cancer 2022. [PMID: 35264777 DOI: 10.1038/s41568-022-00454-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Zanoni M, Pegoraro A, Adinolfi E, De Marchi E. Emerging roles of purinergic signaling in anti-cancer therapy resistance. Front Cell Dev Biol 2022;10:1006384. [DOI: 10.3389/fcell.2022.1006384] [Reference Citation Analysis]
2 Gong L, Wang C, Xu P, Gong J, Zhu C, Di S, Li Y, Mu Y, Han H, Zhang Q, Lin Z. Polymeric Nanoreactors with Chemically Tunable Redox Responsivity. ACS Appl Mater Interfaces 2022. [PMID: 35983858 DOI: 10.1021/acsami.2c07663] [Reference Citation Analysis]
3 Al-warhi T, Abualnaja M, Abu Ali OA, Althobaiti F, Alharthi F, Elsaid FG, Shati AA, Fayad E, Elghareeb D, Abu Almaaty AH, Zaki I. Synthesis and Biological Activity Screening of Newly Synthesized Trimethoxyphenyl-Based Analogues as Potential Anticancer Agents. Molecules 2022;27:4621. [DOI: 10.3390/molecules27144621] [Reference Citation Analysis]